Symmetric
  • TRAINING COURSES
  • IN-HOUSE TRAINING
  • CLIENTS
  • TRAINERS
  • BLOG
  • ABOUT US
  • CONTACT

Join Symmetric Newsletter

Sign up today so you don't miss any special offers, new events and pharma breaking news.

TOP 3 Pharma & Biotech Worldwide News Once a Month

Interviews With Industry Professionals Once Every Three Months

Regular Event Calendar & Special Offers Once Every Six Months

Symmetric s.r.o.

Mliekarenska 7

82109 Bratislava

Slovak Republic

ID: 47 068 124

VAT No: SK2023741973

Office: +421 948 262 346

LinkedIn

Booking & Support

Phone (EU):+421 948 262 346 (9:00 - 17:00 CET)

Phone (US):+1 857 392 2714 (9:00 - 16:00 ET)

Email:info@symmetric.events

A real member of our team answers our chat

Terms & ConditionsPrivacy PolicyChange Your Cookie Consent

© 2026 Symmetric s.r.o.

Contamination Control Strategy
Pharma & Biotech

Contamination Control Strategy

Date to be announced

Contact us for more info
Price available after dates are announced

TRAINING TIMES

  • TBDVienna
  • TBDLondon
  • TBDNew York
  • TBDLos Angeles
Online Training

WHY SHOULD YOU ATTEND?

Grab a systematic evaluation and overview

of CCS requirements as detailed in the EU Annex 1 Manufacture of Sterile Medicinal Products.

Gain knowledge and understanding

on the successful implementation of the CCS and the impact of failed implementations.

Recognise the different elements of the CCS

and how they impact on your Quality System. Check the latest regulations and guidance.

Apply the different roles

within the company organisation and their inputs to a successful implementation of the Contamination Control Strategy.


OUR ONLINE TRAINING EXPERIENCE INCLUDE

Three days of expert-led Zoom sessions packed with discussions, Q&As, and real-world scenarios.

All slides, tools, and supporting materials available in our CLIENT ZONE before, during, and after the course.

Receive a digital certificate (also Linkedin-ready) that verifies your skills in strategic trial planning.


LEARNING OBJECTIVES

Learning Objective

Why is CCS critical in maintaining appropriate controls of contamination?

Overview of the latest regulations and guidance of contamination control strategy and sterile medicinal products

Learning Objective

Review of the different elements of the CCS

Design of the plant and processes including the associated documentation. Premises, equipment, utilities.

Learning Objective

Raw materials, packaging and vendor management elements of the CCS

Raw material controls. Product containers and closures. Vendor approval and outsourced activities.

Learning Objective

Review of process related elements of the CCS

Process risk management, process validation, validation of sterilisation processes, preventative maintenance.

Learning Objective

Cleaning, monitoring and prevention elements

Cleaning and disinfection, monitoring systems, prevention mechanisms, continuous improvement.

Learning Objective

Case study group exercise

Changes in the supply chain sourcing model for a key component in vial products leads to increased risk.


WHO IS THIS TRAINING FOR?

Designed for professionals who want to enhance their expertise and advance their careers

QC/QA Specialists

Quality & Validation Engineers

Process Validation Specialists

Microbiology Specialists

Design Engineers

Supply Chain Specialists

Regulatory Affairs Managers

Manufacturing Technicians


KEY TOPICS

Introduction to Contamination Control Strategy
Development and Implementation of the CCS Elements
Managing Risks to Medicinal Product Quality
Prevention of Cross-contamination in Production
Identifying the Different Controls and Monitoring Measures
Evaluation and Understanding of CCS Requirements

TRAINER

Rob Walker

Rob Walker

Rob Walker GMP Consultancy Limited, Director

Rob Walker is a Chartered Chemist and a Fellow of the Royal Society of Chemistry with degrees in Applied Chemistry and Instrumental Analytical Chemistry. He has over 30-year experience in the Pharmaceutical industry including 25 years as a Qualified Person. After 16 years in senior management at CP Pharmaceuticals, the last 7 as Quality Director, he is now a director of his own GMP consultancy company operating across the Global Market. Rob has extensive GMP Manufacturing and Quality experience covering a wide range of dosage forms, in particular aseptic sterile products, and has successfully managed GMP inspections by MHRA and FDA for primary and secondary manufacturing in the UK and overseas. He has performed GMP audits and training encompassing all elements of the global pharmaceutical supply chain. A member of a number of pharmaceutical industry professional organizations, Rob has delivered numerous presentations to Industry/Regulatory forums in both the EU and the USA on current GMP issues. He has edited technical reports for professional bodies on steam sterilization, and contributed to pharmaceutical industry monographs on media fills and integrity testing of sterile products. He has also represented the UK Pharmaceutical Industry in regulatory meetings in the EU and USA.

Learn More →

Sneak peek

Sneak Peek

Take a sneak peek at the trainer's presentation.

View PDF →